AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions
Aging Cell · 2023
DOI: 10.1111/acel.13961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2023. Verfasst von Mingwei Guo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, …. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Basic Research Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Sarcopenia is characterized of muscle mass loss and functional decline in elder individuals which severely affects human physical activity, metabolic homeostasis, and life quality. Physical exercise is considered effective in combating muscle atrophy and sarcopenia, yet it is not feasible to elders with limited mobility. PGC‐1α4, a short isoform of PGC‐1α, is strongly induced in muscle under resistance training, and promotes muscle hypertrophy. In the present study, we showed that the transcriptional levels and nuclear localization of PGC1α4 was reduced during aging, accompanied with muscle dystrophic morphology, and gene programs. We thus designed NLS‐PGC1α4 and ectopically express it in myotubes to enhance PGC1α4 levels and maintain its location in nucleus. Indeed, NLS‐PGC1α4 overexpression increased muscle sizes in myotubes. In addition, by utilizing AAV‐NLS‐PGC1α4 delivery into gastrocnemius muscle, we found that it could improve sarcopenia with grip strength, muscle weights, fiber size and molecular phenotypes, and alleviate age‐associated adiposity, insulin resistance and hepatic steatosis, accompanied with altered gene signatures. Mechanistically, we demonstrated that NLS‐PGC‐1α4 improved insulin signaling and enhanced glucose uptake in skeletal muscle. Besides, via RNA‐seq analysis, we identified myokines IGF1 and METRNL as potential targets of NLS‐PGC‐1α4 that possibly mediate the improvement of muscle and adipose tissue functionality and systemic energy metabolism in aged mice. Moreover, we found a negative correlation between PGC1α4 and age in human skeletal muscle. Together, our results revealed that NLS‐PGC1α4 overexpression improves muscle physiology and systematic energy homeostasis during aging and suggested it as a potent therapeutic strategy against sarcopenia and aging‐associated metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
- Department of Orthopedics, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolism, Fengxian Central Hospital Affiliated to Southern Medical University, Shanghai, China.
- Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
- Key Laboratory of Adolescent Health Assessment and Exercise Intervention of Ministry of Education, College of Physical Education and Health, East China Normal University, Shanghai, China.
- Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai, China.
ORCID-Profile: Mingwei Guo, Xinran Ma
Förderung
- Fundamental Research Funds for the Central Universities
- National Basic Research Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Guo, M., Zhang, J., Ma, Y., Zhu, Z., Zuo, H., Yao, J., Wu, X., Wang, D., Yu, J., Meng, M., Liu, C., Zhang, Y., Chen, J., Lu, J., Ding, S., Hu, C., Ma, X., & Xu, L. (2023). AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions. Aging Cell. https://doi.org/10.1111/acel.13961
Vancouver
Guo M, Zhang J, Ma Y, Zhu Z, Zuo H, Yao J, et al. AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions. Aging Cell. 2023. doi:10.1111/acel.13961
BibTeX
@article{Guo2023,
author = {Guo, Mingwei and Zhang, Jun and Ma, Ying and Zhu, Zhenzhong and Zuo, Hui and Yao, Jing and Wu, Xia and Wang, Dongmei and Yu, Jian and Meng, Meiyao and Liu, Caizhi and Zhang, Yi and Chen, Jiangrong and Lu, Jian and Ding, Shuzhe and Hu, Cheng and Ma, Xinran and Xu, Lingyan},
title = {AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.13961}
}
EUVIMED